Across TCGA pan-cancer cohorts, RNA5SP496 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNA5SP496’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RNA5SP496 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP496 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BLCA, KIRC, and KICH are the cancer types where RNA5SP496 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP496 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.523	.001	5	view →
KIRC	Male	II,III,IV	+0.102	.019	5	view →
KICH	All	II,III,IV	+0.358	.014	3	view →
LUSC	All	All	+0.217	.038	1	view →
THCA	Female	All	−0.139	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNA5SP496 RNA expression & survival · all RNA5SP496 data types